https://www.selleckchem.com/pr....oducts/Fulvestrant.h
39 ± 3.39, P = 0.00. During the follow-up, none of the patients experienced any severe complications, and the rate of vaginal erosion was 20% (12/6. The PFIQ-7 score in the 1-month follow-up decreased more than 50% and was associated with continuous pessary use [OR 20.75, P = 0.027, 95% CI (2.28, 189.27)]. CONCLUSIONS Successful pessary use can be defined as fitting for longer than 3 months. The PFIQ-7 scores should be focused on during the follow-up. The treatment should be changed if the scores decrease less than 50% in the 1-